Movement compensation during carbon dioxide coronary angiography: In-vitro validation

The aim of this in vitro study was to evaluate the feasibility of movement compensation for CO2 coronary angiography. The use of CO2 as a contrast medium for coronary angiography in a routine clinical setting is still premature. Nonetheless, the gas can solve most of the problems related to iodine c...

Full description

Bibliographic Details
Main Authors: Ivan Corazza, Sonia Sapignoli, Pier Luca Rossi, Alessandro Lombi, Edoardo Pirazzini, Nevio Taglieri, James G. Caridi, Romano Zannoli
Format: Article
Language:English
Published: AIP Publishing LLC 2018-09-01
Series:AIP Advances
Online Access:http://dx.doi.org/10.1063/1.5030796
id doaj-a825b783d8554c34a718142dfcb67fe2
record_format Article
spelling doaj-a825b783d8554c34a718142dfcb67fe22020-11-25T02:30:52ZengAIP Publishing LLCAIP Advances2158-32262018-09-0189095005095005-710.1063/1.5030796009809ADVMovement compensation during carbon dioxide coronary angiography: In-vitro validationIvan Corazza0Sonia Sapignoli1Pier Luca Rossi2Alessandro Lombi3Edoardo Pirazzini4Nevio Taglieri5James G. Caridi6Romano Zannoli7Experimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyExperimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyDepartment of Physics and Astronomy, University of Bologna, Viale Berti Pichat 6/2, 40127 Bologna, ItalyDepartment of Physics and Astronomy, University of Bologna, Viale Berti Pichat 6/2, 40127 Bologna, ItalyExperimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyExperimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyHealth Sciences Center, Tulane University, 1430 Tulane Avenue, New Orleans, Louisiana 70112-2699, USAExperimental, Diagnostic and Specialty Medicine Department, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyThe aim of this in vitro study was to evaluate the feasibility of movement compensation for CO2 coronary angiography. The use of CO2 as a contrast medium for coronary angiography in a routine clinical setting is still premature. Nonetheless, the gas can solve most of the problems related to iodine contrast-induced nephropathy and can be safely used for patients with renal insufficiency. In a previous work [I. Corazza et al., AIP Adv. 8(1), 015225 (2018)], we demonstrated that an adequate setting of the CO2 injection parameters (pressures and volumes) allows gas injection into the coronaries, avoiding reflux into the aorta and cerebral circulation. A mechanical mock simulating coronary circulation and movement was used to simulate different CO2 injection conditions. Simultaneous acquisition of ECG and optical images allowed synchronous frame extraction for post-processing analysis, like masking and stacking processes. A single test with a radiological apparatus was done to demonstrate the feasibility of the technique. By injecting CO2 at a pressure between the dicrotic notch and diastolic value, no reflux into the aorta was observed and the new software yielded final optical images of clinical quality after about 8 seconds of injection. The feasibility test under the X-ray apparatus gave promising results. CO2 coronary angiography is still far from becoming a clinical standard, but our bench evaluation demonstrates that if the injection parameters are well-controlled and physiological values known, CO2 can be used as a contrast agent not only for the lower part of the body, but also for the coronary arteries, respecting basic safety standards.http://dx.doi.org/10.1063/1.5030796
collection DOAJ
language English
format Article
sources DOAJ
author Ivan Corazza
Sonia Sapignoli
Pier Luca Rossi
Alessandro Lombi
Edoardo Pirazzini
Nevio Taglieri
James G. Caridi
Romano Zannoli
spellingShingle Ivan Corazza
Sonia Sapignoli
Pier Luca Rossi
Alessandro Lombi
Edoardo Pirazzini
Nevio Taglieri
James G. Caridi
Romano Zannoli
Movement compensation during carbon dioxide coronary angiography: In-vitro validation
AIP Advances
author_facet Ivan Corazza
Sonia Sapignoli
Pier Luca Rossi
Alessandro Lombi
Edoardo Pirazzini
Nevio Taglieri
James G. Caridi
Romano Zannoli
author_sort Ivan Corazza
title Movement compensation during carbon dioxide coronary angiography: In-vitro validation
title_short Movement compensation during carbon dioxide coronary angiography: In-vitro validation
title_full Movement compensation during carbon dioxide coronary angiography: In-vitro validation
title_fullStr Movement compensation during carbon dioxide coronary angiography: In-vitro validation
title_full_unstemmed Movement compensation during carbon dioxide coronary angiography: In-vitro validation
title_sort movement compensation during carbon dioxide coronary angiography: in-vitro validation
publisher AIP Publishing LLC
series AIP Advances
issn 2158-3226
publishDate 2018-09-01
description The aim of this in vitro study was to evaluate the feasibility of movement compensation for CO2 coronary angiography. The use of CO2 as a contrast medium for coronary angiography in a routine clinical setting is still premature. Nonetheless, the gas can solve most of the problems related to iodine contrast-induced nephropathy and can be safely used for patients with renal insufficiency. In a previous work [I. Corazza et al., AIP Adv. 8(1), 015225 (2018)], we demonstrated that an adequate setting of the CO2 injection parameters (pressures and volumes) allows gas injection into the coronaries, avoiding reflux into the aorta and cerebral circulation. A mechanical mock simulating coronary circulation and movement was used to simulate different CO2 injection conditions. Simultaneous acquisition of ECG and optical images allowed synchronous frame extraction for post-processing analysis, like masking and stacking processes. A single test with a radiological apparatus was done to demonstrate the feasibility of the technique. By injecting CO2 at a pressure between the dicrotic notch and diastolic value, no reflux into the aorta was observed and the new software yielded final optical images of clinical quality after about 8 seconds of injection. The feasibility test under the X-ray apparatus gave promising results. CO2 coronary angiography is still far from becoming a clinical standard, but our bench evaluation demonstrates that if the injection parameters are well-controlled and physiological values known, CO2 can be used as a contrast agent not only for the lower part of the body, but also for the coronary arteries, respecting basic safety standards.
url http://dx.doi.org/10.1063/1.5030796
work_keys_str_mv AT ivancorazza movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation
AT soniasapignoli movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation
AT pierlucarossi movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation
AT alessandrolombi movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation
AT edoardopirazzini movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation
AT neviotaglieri movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation
AT jamesgcaridi movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation
AT romanozannoli movementcompensationduringcarbondioxidecoronaryangiographyinvitrovalidation
_version_ 1724827208944451584